Review Article

Opportunities and Limitations of Vascular Risk Factor Models in Studying Plasticity-Promoting and Restorative Ischemic Stroke Therapies

Table 1

Animal models of hypercholesterolemia used in ischemic stroke studies.

Animal modelBlood cholesterol concentrationsSystemic vascular pathologyCerebrovascular features

ApoE-/- mouseIncreased 4.3-8 times on regular diet, elevated additional 1.4-2.7 times on high-cholesterol diet [7, 8]Fatty streaks in aortic wall and extracranial carotid arteries after 6 weeks that are exacerbated by high-cholesterol diet and then associated with lipid deposition in brain arterioles [7, 9]. Upon high-cholesterol diet atherosclerotic plaque formation within 6 months [9]Infarct volume, blood-brain barrier permeability, and neurological deficits after transient proximal MCAO or transient distal MCAO increased in ApoE-/- mice on high-cholesterol diet [7ā€“10]. Vasorelaxation and VEGF-induced angiogenesis were compromised, resulting in reduced cerebral blood flow [7ā€“11]. Increase of infarct volume and blood-brain barrier permeability mediated by RhoA overactivation and brain neutrophil invasion [7, 8, 10]

LDL receptor-/- mouseIncreased 1.9-2.4 times on regular diet, elevated additional 1.5 times on high-cholesterol diet [12]Little vascular abnormalities under normal diet [12]. Upon high-cholesterol diet, atherosclerotic plaque formation in aortic wall and coronary arteries after 5-7 months [12]Thrombotic occlusions of cerebral microvessels and occasional microhemorrhages in LDL receptor-/- mice on high-cholesterol diet at ~6 months [14]. Infarct volume after transient proximal MCAO unaffected by LDL receptor-/- [16]. Platelet deactivation by antiglycoprotein-Ib and antiglycoprotein-VI antibody reduced infarct volume and neurological deficits in 12-month-old LDL receptor-/- and wild-type mice without increasing hemorrhagic transformation [16]. Glycoprotein-IIb/IIIa inhibition had no effect [16]

Human ApoB transgenic (hApoBTg) mouseIncreased 1.3-1.8 times on regular diet, elevated additional 2.2 times on high-cholesterol diet [13]Little vascular abnormalities under normal diet [13]. Upon high-cholesterol diet, atherosclerotic plaque formation in aortic wall that is more severe in female than male mice after 4 months [13]Brain capillary density reduced in hApoBTg mice upon high-cholesterol diet after ~6 months, suggestive of spontaneous microvascular occlusions [15]. Microvascular injury after unilateral common carotid artery occlusion not influenced by transgenic ApoB in mice exposed to high-cholesterol diet [15]

High-cholesterol diet in wild-type mouseIncreased 2.2-3.9 times in C57BL6 mouse [11, 13]Modest fatty streaks in the aorta even after several months of high-cholesterol diet [13]. Metabolic syndrome characterized by obesity, type-2 diabetes, and hypercholesterolemia [23] with lipid deposition in cerebral arterioles [7]Blood-brain barrier permeability, calpain-1/2 activity, matrix metalloproteinase-2/9 activity, and brain edema after transient proximal MCAO increased in C57BL6 mice on high-cholesterol diet presumably due to RhoA overactivation [7]. Infarct volume and neuronal injury unchanged [7, 11]

High-cholesterol diet in ratIncreased 2.1-4.2 times in Sprague-Dawley rat [26, 27]Modest fatty streaks in the aorta even after several months of high-cholesterol diet [26, 27]Infarct volume, blood-brain barrier permeability, brain edema, brain lipid peroxidation, and brain leukocyte infiltration after transient proximal MCAO increased in Sprague-Dawley rats on high-cholesterol diet [26, 27]. Changes prevented by simvastatin and ginkgolide-B [26]

High-cholesterol diet in rabbitLDL increased 34.7 times [28]Atheromas of internal carotid and basilar arteries after 5 weeks of high-cholesterol diet [28]Number of hemorrhagic infarcts reduced, but infarct size increased in rabbits on high-cholesterol diet exposed to focal cerebral ischemia induced by sephadex-G75 polymer [28]. Increased infarct size associated with accumulation of platelet-rich thrombi in infarct foci [28]

Modified from Reference [6].